Brief: EMA's CHMP Announces Positive Recommendation On Extension Of Therapeutic Indications For Koselugo

Viatris

14/11/2025 11:47

Nov 14 (Reuters) - EMA's CHMP:

EMA'S CHMP:  POSITIVE RECOMMENDATIONS ON EXTENSIONS OF THERAPEUTIC INDICATIONS FOR KOSELUGO

EMA'S CHMP: RECOMMENDS MARKETING AUTHORISATION FOR DAWNZERA - WEBSITE

EMA'S CHMP: INLURIYO RECEIVES POSITIVE OPINION

EMA'S CHMP:  ADOPTED POSITIVE OPINION FOR WASKYRA (ETUVETIDIGENE AUTOTEMCEL), FIRST GENE THERAPY TO TREAT WISKOTT-ALDRICH SYNDROME

EMA'S CHMP: ADOPTS POSITIVE OPINION FOR TEIZEILD

EMA'S CHMP: APPLICATION FOR OHTUVAYRE WITHDRAWN

EMA'S CHMP: APPLICATION FOR NURZIGMA WITHDRAWN

EMA'S CHMP: TEDUGLUTIDE RECEIVES POSITIVE OPINION

Source text: [ID:]

Further company coverage: AZN.L

 ((Reuters.Briefs@thomsonreuters.com))